{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-047912","form_type":"8-K","ticker":"UTHR","cik":"0001082554","company_name":"UNITED THERAPEUTICS Corp","filed_at":"2023-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.883180+00:00","generated_at":"2026-06-16T21:05:27.665240+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"United Therapeutics amends bylaws to enhance stockholder proposal and nomination procedures","bullets":["Amendments require additional background info on proposing stockholders and nominees, and representation on solicitation intentions.","Updates procedural mechanics for adjourned meetings, inspectors of election, and proxy revocability.","Eliminates stockholder list inspection at meetings; opts out of DGCL Section 116 for written delivery of notices.","Certificates and uncertificated shares must conspicuously state company is a public benefit corporation."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-047912","json":"https://secwatch.observer/filing/0001104659-23-047912.json","markdown":"https://secwatch.observer/filing/0001104659-23-047912.md","text":"https://secwatch.observer/filing/0001104659-23-047912.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1082554/000110465923047912/0001104659-23-047912-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/000110465923047912/tm2313121d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T21:05:27.665240+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"13e62b9debe30f4203599d701b98cd5ead9ae815","claim":"UNITED THERAPEUTICS Corp: Adopted Tenth Amended and Restated Bylaws with various amendments including enhanced stockholder proposal and director nomination procedures, adjourned meeting mechanics, proxy rules, and technical changes (effective 2023-04-20).","evidence_excerpt":"On April 20, 2023, the Board of Directors (the “ Board ”) of United Therapeutics Corporation (the “ Company ”) approved and adopted the Company’s Tenth Amended and Restated Bylaws (as amended and restated, the “ Bylaws ”), which became effective the same day.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1082554/000110465923047912/0001104659-23-047912-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-04-20"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}